Sepsis (Pseudomonas aeruginosa)

Overview

Plain-Language Overview

Sepsis (Pseudomonas aeruginosa) is a serious infection that affects the whole body and occurs when bacteria enter the bloodstream. This condition primarily impacts the immune system and can cause widespread inflammation, leading to damage in multiple organs such as the lungs, kidneys, and heart. The bacteria Pseudomonas aeruginosa is known for being resistant to many antibiotics, making the infection harder to treat. Symptoms often include fever, rapid heartbeat, and confusion. If not treated promptly, it can lead to severe complications like organ failure and shock.

Clinical Definition

Sepsis (Pseudomonas aeruginosa) is a life-threatening syndrome characterized by a dysregulated host response to infection, leading to systemic inflammation and potential organ dysfunction. It is caused by the gram-negative bacterium Pseudomonas aeruginosa, which produces endotoxins and exotoxins that trigger a robust immune response. This pathogen is notable for its antibiotic resistance and ability to form biofilms, complicating treatment. The condition is clinically significant due to its high morbidity and mortality rates, especially in immunocompromised patients or those with invasive devices. Key features include hypotension, tachycardia, and evidence of organ hypoperfusion. Early recognition and management are critical to prevent progression to septic shock and multi-organ failure.

Inciting Event

Inoculation of Pseudomonas aeruginosa into bloodstream via contaminated catheters or wounds initiates sepsis.
Ventilator-associated pneumonia caused by Pseudomonas can precipitate systemic infection.
Urinary tract infections with Pseudomonas in catheterized patients may lead to bacteremia.
Burn wound colonization with Pseudomonas often precedes sepsis.

Latency Period

Rapid onset within hours to days after bacterial entry into bloodstream is typical.
Symptoms often develop within 24-72 hours following invasive procedures or infection onset.
Latency may be shorter in immunocompromised hosts due to impaired containment.

Diagnostic Delay

Nonspecific early symptoms such as fever and malaise can mimic other infections, delaying diagnosis.
Negative initial blood cultures may occur if antibiotics were started empirically.
Misattribution to other gram-negative sepsis without specific identification of Pseudomonas delays targeted therapy.
Lack of suspicion in community settings may postpone appropriate diagnostic testing.

Patient Population

Hospitalized patients, especially in intensive care units, are most commonly affected.
Immunocompromised adults and children represent a high-risk group.
Patients with chronic lung disease such as cystic fibrosis or bronchiectasis are frequently affected.
Burn victims and trauma patients are at increased risk due to skin barrier disruption.

Risk Factors

Immunocompromise, including neutropenia and HIV/AIDS, increases susceptibility to Pseudomonas sepsis.
Hospitalization with invasive devices such as central venous catheters or mechanical ventilation predisposes to infection.
Broad-spectrum antibiotic use disrupts normal flora, facilitating Pseudomonas overgrowth and resistance.
Burn injuries and chronic wounds provide portals of entry for Pseudomonas.
Cystic fibrosis patients have chronic Pseudomonas colonization increasing sepsis risk.

Clinical Presentation

Signs & Symptoms

High fever or hypothermia with chills
Hypotension causing dizziness or syncope
Tachypnea and respiratory distress
Confusion or decreased level of consciousness
Skin manifestations such as ecthyma gangrenosum characteristic of Pseudomonas infection

History of Present Illness

Acute onset of high fever, chills, and rigors is common in Pseudomonas sepsis.
Rapid progression to hypotension and signs of shock often occurs within hours.
Patients may report localized symptoms related to primary infection site, such as purulent wound drainage or respiratory distress.
Confusion or altered mental status may develop as sepsis worsens.

Past Medical History

Recent hospitalization or ICU stay with invasive devices is a key risk factor.
History of immunosuppressive therapy or neutropenia increases susceptibility.
Chronic lung diseases like cystic fibrosis or bronchiectasis predispose to colonization and infection.
Previous broad-spectrum antibiotic use may select for resistant Pseudomonas strains.

Family History

[]

Physical Exam Findings

Fever or hypothermia with tachycardia and tachypnea indicating systemic inflammatory response
Hypotension refractory to fluid resuscitation suggesting septic shock
Petechiae or purpura due to disseminated intravascular coagulation
Altered mental status ranging from confusion to coma
Cold extremities with delayed capillary refill indicating poor perfusion

Diagnostic Workup

Diagnostic Criteria

Diagnosis of sepsis involves identifying a suspected or confirmed infection with Pseudomonas aeruginosa alongside clinical signs of systemic inflammation such as fever, tachycardia, and tachypnea. Laboratory confirmation requires positive blood cultures or cultures from a normally sterile site isolating Pseudomonas aeruginosa. The presence of organ dysfunction is assessed using the Sequential Organ Failure Assessment (SOFA) score, with an increase of 2 or more points indicating sepsis. Additional findings include elevated lactate levels and leukocytosis or leukopenia.

Pathophysiology

Key Mechanisms

Endotoxin (lipopolysaccharide) release from Pseudomonas aeruginosa triggers a systemic inflammatory response via TLR4 activation and massive cytokine release (TNF-alpha, IL-1, IL-6).
Exotoxins and proteases produced by Pseudomonas cause direct tissue damage and impair host defenses.
Neutrophil activation and endothelial injury lead to increased vascular permeability, hypotension, and disseminated intravascular coagulation (DIC).
Biofilm formation by Pseudomonas enhances resistance to host immunity and antibiotics, promoting persistent infection.
Impaired microcirculation results in tissue hypoxia and multi-organ dysfunction characteristic of severe sepsis.

Involvement	Details
Organs	Lungs are frequently involved in sepsis, often developing acute respiratory distress syndrome with impaired gas exchange.
	Kidneys are vulnerable to acute injury from hypoperfusion and inflammatory damage during sepsis.
	Heart may develop septic cardiomyopathy characterized by decreased contractility and hypotension.
	Liver dysfunction occurs due to hypoperfusion and inflammatory injury, impairing metabolism and coagulation.
Tissues	Vascular endothelium is critically involved in sepsis pathophysiology by mediating increased permeability and microvascular thrombosis.
Tissues	Lung tissue is commonly affected in sepsis, leading to acute respiratory distress syndrome due to inflammation and edema.
Cells	Neutrophils are the primary immune cells that phagocytose and kill Pseudomonas aeruginosa during sepsis.
	Macrophages produce proinflammatory cytokines that amplify the systemic inflammatory response in sepsis.
	Endothelial cells become activated and contribute to increased vascular permeability and coagulopathy in sepsis.
Chemical Mediators	Tumor necrosis factor-alpha (TNF-α) is a key proinflammatory cytokine driving systemic inflammation in sepsis.
	Interleukin-1 (IL-1) promotes fever and leukocyte activation during the septic response.
	Prostaglandins mediate vasodilation and contribute to hypotension in septic shock.
	Nitric oxide (NO) produced by inducible nitric oxide synthase causes vasodilation and vascular collapse in severe sepsis.

Treatments

Pharmacological Treatments

Piperacillin-tazobactam
- Mechanism:
  - Broad-spectrum beta-lactam antibiotic inhibiting bacterial cell wall synthesis combined with beta-lactamase inhibitor to overcome resistance.
- Side effects:
  - Allergic reactions
  - Nephrotoxicity
  - Electrolyte disturbances
- Clinical role:
  - First-line
Ceftazidime
- Mechanism:
  - Third-generation cephalosporin that inhibits bacterial cell wall synthesis, effective against Pseudomonas aeruginosa.
- Side effects:
  - Hypersensitivity reactions
  - Neutropenia
  - Elevated liver enzymes
- Clinical role:
  - First-line
Ciprofloxacin
- Mechanism:
  - Fluoroquinolone that inhibits bacterial DNA gyrase and topoisomerase IV, leading to bacterial DNA replication inhibition.
- Side effects:
  - Tendonitis
  - QT prolongation
  - Gastrointestinal upset
- Clinical role:
  - Second-line
Amikacin
- Mechanism:
  - Aminoglycoside that binds 30S ribosomal subunit causing misreading of mRNA and bacterial protein synthesis inhibition.
- Side effects:
  - Ototoxicity
  - Nephrotoxicity
  - Neuromuscular blockade
- Clinical role:
  - Adjunctive
Meropenem
- Mechanism:
  - Carbapenem antibiotic that inhibits bacterial cell wall synthesis with broad activity including resistant Pseudomonas aeruginosa strains.
- Side effects:
  - Seizures
  - Hypersensitivity reactions
  - Gastrointestinal upset
- Clinical role:
  - Second-line

Non-pharmacological Treatments

Aggressive intravenous fluid resuscitation to maintain tissue perfusion and prevent shock.
Vasopressor support such as norepinephrine for persistent hypotension despite fluid resuscitation.
Source control including drainage of abscesses or removal of infected devices.
Mechanical ventilation for respiratory failure due to sepsis-induced acute respiratory distress syndrome.
Continuous monitoring of vital signs and organ function in an intensive care setting.

Prevention

Pharmacological Prevention

Antibiotic prophylaxis in high-risk neutropenic patients
Selective digestive decontamination in ICU patients to reduce Pseudomonas colonization
Vaccination against common pathogens to reduce secondary infections
Appropriate antimicrobial stewardship to prevent resistance
Use of granulocyte colony-stimulating factor in neutropenic patients

Non-pharmacological Prevention

Strict hand hygiene to prevent nosocomial transmission
Aseptic technique during catheter insertion and care
Early removal of invasive devices to reduce infection risk
Environmental cleaning and disinfection in healthcare settings
Screening and isolation of colonized or infected patients

Outcome & Complications

Complications

Septic shock with multiorgan failure
Acute respiratory distress syndrome (ARDS) from systemic inflammation
Disseminated intravascular coagulation (DIC) causing bleeding and thrombosis
Endocarditis or metastatic abscesses from hematogenous spread
Renal failure due to acute tubular necrosis

Short-term Sequelae	Long-term Sequelae
Prolonged hypotension requiring vasopressors Mechanical ventilation for respiratory failure Acute kidney injury necessitating dialysis Secondary infections due to immune dysregulation Neurologic deficits from septic encephalopathy	Chronic organ dysfunction including renal and pulmonary impairment Neuromuscular weakness from critical illness polyneuropathy Cognitive impairment and post-intensive care syndrome Recurrent infections due to immune system alterations Psychological disorders such as PTSD and depression

Differential Diagnoses

Sepsis (Pseudomonas aeruginosa) versus Sepsis due to Staphylococcus aureus

Sepsis (Pseudomonas aeruginosa)	Sepsis due to Staphylococcus aureus
Gram-negative rods	Gram-positive cocci in clusters
Exposure to moist environments or contaminated water	Recent skin infection or intravenous catheter use
Requires antipseudomonal beta-lactams such as piperacillin-tazobactam	Responds to nafcillin or vancomycin

Sepsis (Pseudomonas aeruginosa) versus Sepsis due to Klebsiella pneumoniae

Sepsis (Pseudomonas aeruginosa)	Sepsis due to Klebsiella pneumoniae
Non-mucoid gram-negative rods with characteristic blue-green pigment	Gram-negative encapsulated rods with mucoid colonies
Non-lactose fermenting on MacConkey agar	Lactose fermenting on MacConkey agar
Common in immunocompromised patients with burns or neutropenia	Common in alcoholics and diabetics with aspiration pneumonia

Sepsis (Pseudomonas aeruginosa) versus Sepsis due to Candida albicans

Sepsis (Pseudomonas aeruginosa)	Sepsis due to Candida albicans
Gram-negative rods	Yeast with pseudohyphae on microscopy
Occurs in neutropenic or immunocompromised but also in burn patients	Occurs mainly in neutropenic or immunosuppressed patients
Positive blood culture with oxidase-positive gram-negative rods	Positive blood culture with budding yeast

Sepsis (Pseudomonas aeruginosa) versus Sepsis due to Escherichia coli

Sepsis (Pseudomonas aeruginosa)	Sepsis due to Escherichia coli
Gram-negative rods, non-lactose fermenting, oxidase positive	Gram-negative rods, lactose fermenting, indole positive
Burn wounds or contaminated water exposure	Urinary tract infections or intra-abdominal infections
Negative indole test	Positive indole test